Reaction

Ureteric Compression reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 75 reports · 4 co-occurring drugs

As of the last recalculation, Ureteric Compression appears in 75 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is FONDAPARINUX SODIUM (PRR 489.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fondaparinux Sodium12489.7490.4
Polatuzumab Vedotin10328.0328.3
Insulin Glargine-Yfgn15237.7237.9
Bendamustine Hcl9182.9183.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.